Company News, Patents

Fuji Chemical Granted Inflammation Patent

Author Image

By: TOM BRANNA

Editor

Patent No. US 7,078,040 B2: Fuji Chemical Industry Co., Ltd., Mount Laurel, NJ has been granted a patent for inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxanthin. Fuji’s pending patents for astaxanthin include the areas of eye fatigue, wrinkle reduction, weight loss, diabetic nephropathy and dyspepsia....

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters